Lanzamiento Enero 2027

Estudio2018Solo mecanismosAcceso abierto

Elucidating the Role of CD84 and AHR in Modulation of LPS-Induced Cytokines Production by Cruciferous Vegetable-Derived Compounds Indole-3-Carbinol and 3,3'-Diindolylmethane

Wang TTY, Pham Q, Kim YS

International journal of molecular sciences · 14 citas

Etiquetas de revisión

Solo mecanismos

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Estudio in vitro o de mecanismos (clasificado por nuestro filtro de IA)
Estudiado en
Células o muestras de laboratorio
Resultado principal
Solo mecanismos

Quién lo pagó

Financiación
Financiación independiente
Gobierno
U.S. Department of Agriculture
Gobierno
National Cancer Institute
Subvenciones
U.S. Department of Agriculture (8040-51530-056-00D)

Según 2 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2018-01-24 · Int J Mol Sci · vol. 19 · número 2 · pág. 339
Editorial
Multidisciplinary Digital Publishing Institute
Citado
26 citas · más que el 72% de estudios similares · 0.9× el promedio de su campo
Referencias
42 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Genomics, phytochemicals, and oxidative stress · Immune Cell Function and Interaction · Immune Response and Inflammation
Palabras clave
Aryl hydrocarbon receptor, Monocyte, Signal transduction, Immune system, Biology, Lipopolysaccharide, Gene knockdown, Cancer research, Cell biology, Chemistry, Immunology, Biochemistry, Transcription factor, Apoptosis
MeSH
monocytes, cell line, macrophages, humans, brassicaceae, vegetables, indoles, cytochrome p-450 cyp1a1, lipopolysaccharides, receptors, aryl hydrocarbon, rna, small interfering, cytokines, gene expression, rna interference, cytochrome p-450 cyp1b1, signaling lymphocytic activation molecule family

3 autores

  • Thomas J. Wang🇺🇸 · autor de correspondenciaAgricultural Research Service; United States Department of Agriculture; Beltsville Human Nutrition Research Center
  • Quynhchi Pham🇺🇸Agricultural Research Service; United States Department of Agriculture; Beltsville Human Nutrition Research Center
  • Young Kim🇺🇸 · autor de correspondenciaNational Cancer Institute

Resumen

El texto original del estudio, en el idioma en que se publicó.

Modulation of the immune system by cancer protective food bioactives has preventive and therapeutic importance in prostate cancer, but the mechanisms remain largely unclear. The current study tests the hypothesis that the diet-derived cancer protective compounds, indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM), affect the tumor microenvironment by regulation of inflammatory responses in monocytes and macrophages. We also ask whether I3C and DIM act through the aryl hydrocarbon (AHR)-dependent pathway or the signaling lymphocyte activation molecule (SLAM) family protein CD84-mediated pathway. The effect of I3C and DIM was examined using the human THP-1 monocytic cell in its un-differentiated (monocyte) and differentiated (macrophage) state. We observed that I3C and DIM inhibited lipopolysaccharide (LPS) induction of IL-1β mRNA and protein in the monocyte form but not the macrophage form of THP-1. Interestingly, CD84 mRNA but not protein was inhibited by I3C and DIM. AHR siRNA knockdown experiments confirmed that the inhibitory effects of I3C and DIM on IL-1β as well as CD84 mRNA are regulated through AHR-mediated pathways. Additionally, the AHR ligand appeared to differentially regulate other LPS-induced cytokines expression. Hence, cross-talk between AHR and inflammation-mediated pathways, but not CD84-mediated pathways, in monocytes but not macrophages may contribute to the modulation of tumor environments by I3C and DIM in prostate cancer.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.